• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.85% Nasdaq Down 1.26%

    Vertex Pharmaceuticals Incorporated (VRTX)

    -NasdaqGS
    126.33 Down 0.20(0.16%) 3:16PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:126.53
    Open:124.30
    Bid:126.18 x 200
    Ask:126.30 x 200
    1y Target Est:140.65
    Beta:1.19778
    Earnings Date:Oct 26 - Oct 30 (Est.)
    Day's Range:123.81 - 127.14
    52wk Range:91.04 - 143.45
    Volume:709,077
    Avg Vol (3m):1,620,840
    Market Cap:30.91B
    P/E (ttm):N/A
    EPS (ttm):-3.08
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    VRTXDown 0.16%30.91B
    MRKDown 2.09%145.19B
    BMYDown 3.03%95.00B
    PTCTDown 0.03%1.30B

    Key Statistics

    Forward P/E (1 yr):30.73
    P/S (ttm):49.28
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.27
    Quarterly EPS Est (Sep-15) :-0.26
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-3.33

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback